NCT01067482

Completed

The Performances of Spectral Domain Optical Coherence Tomogr...

Prince of Songkla University Source

Compare

Other study identifiers

Sponsor study identifier

EC 52-336-02-1-2

Study Type

observational

Estimated enrollment

80

Locations

1 country

Sites

1

Timeline

Study Start

September 2009

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

March 2010

Actual (reported)

Study Completion

March 2010

Actual (reported)

Brief Summary

The purpose of this study is to evaluate performances of each parameters of spectral domain (Cirrus) optical coherence tomography for distinguishing between normal eyes, glaucoma suspect and glaucomatous eyes

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Estimated enrollment: 80 participants
Study completion date: March 2010
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
September 2009
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
February 10, 2010
Actual (reported)
First Posted
February 11, 2010
Actual (reported)
Primary Completion
March 2010
Actual (reported)
Study Completion
March 2010
Actual (reported)

Last Updated: March 23, 2010
Status Verified: October 2009
Last Update Submitted: March 22, 2010

Conditions

Glaucoma Patient Glaucoma Suspect Patient Macular Thickness by Location Normal Population RNFL Thickness by Location

Keywords

OCTspectral domain cirrusglaucomaglaucoma suspectnormal population

Study Arms (3)

Glaucoma patients

Glaucoma suspect group

Normal population

Eligibility Criteria

Age18 Years - 80 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodProbability Sample

Study Population

glaucoma patient from glaucoma clinic that is POAG Glaucoma suspect cases normal population case

You may qualify if:

BCVA at least 20/60

Sponsors & Collaborators

Prince of Songkla University
Otherlead

Study Sites (1)

Glaucoma unit , Department of Ophthalmology Faculty of Medicine Prince of Songkla University

Hat Yai, Songkhla, Thailand., 90110, Thailand

MeSH Terms

Conditions

GlaucomaOcular Hypertension

Condition Hierarchy (Ancestors)

Eye Diseases

Study Officials

Weerawat Kiddee, MD
Prince of Songkla University
PRINCIPAL INVESTIGATOR

Study Design

Study Type: observational
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER

Study Record Dates

First Submitted

February 10, 2010

First Posted

February 11, 2010

Study Start

September 2009

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

March 2010

Actual (reported)

refractive error +/- 5 D Or astig +/- 3 D

enrolled in 3 population group (glaucoma, glaucoma suspect or normal)

You may not qualify if:

VA less than 20/60
marked RF error
previous ocular trauma or surgery
unreliable visual field
poor signal cirrus OCT (less than 7)
other causes of optic nerve or macular disease other than glaucoma

Contact the study team to confirm eligibility.

Study Completion

March 2010

Actual (reported)

Last Updated

March 23, 2010

Record last verified: 2009-10

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT01067482
Data provider: ClinicalTrials.gov
Source updated: 2010-03-23
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:33:26 UTC

Locations

TH(1)

The Performances of Spectral Domain Optical Coherence Tomography (OCT) for Distinguishing Glaucomatous Eyes

The Performances of Spectral Domain Optical Coherence Tomography (OCT) for Distinguishing Glaucomatous Eyes

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Study Arms (3)

Glaucoma patients

Glaucoma suspect group

Normal population

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Study Arms (3)

Glaucoma patients

Glaucoma suspect group

Normal population

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations